论文部分内容阅读
目的 :探讨前列腺癌患者血清PSA与前列腺癌病理分级和临床分期的相关性。方法 :前列腺手术前检测PSA ,术后经病理检查确诊为前列腺癌患者 42例。根据苏木素 伊红染色切片中肿瘤的组织学形态 ,结合临床资料分别进行病理分级、临床分期。采用Spearman等级相关分析分析PSA与前列腺癌病理分级和临床分期的关系。结果 :PSA值与前列腺癌的病理分级有关 ,与前列腺癌临床分期间的关系目前尚无肯定的结论。结论 :PSA值不仅是前列腺癌的一个筛选指标 ,而且可能是判断前列腺癌预后的一个有意义的指标
Objective: To investigate the correlation between serum PSA and the pathological grade and clinical stage of prostate cancer in patients with prostate cancer. Methods: Prostate surgery before the detection of PSA, postoperative pathological examination confirmed 42 cases of prostate cancer patients. According to histological morphology of the tumor in hematoxylin and eosin staining sections, pathological grade and clinical stage were respectively combined with clinical data. Spearman rank correlation analysis was used to analyze the relationship between PSA and the pathological grade and clinical stage of prostate cancer. Results: The PSA value was related to the pathological grade of prostate cancer and the relationship with the clinical stage of prostate cancer was not conclusive at present. Conclusion: The PSA value is not only a screening index for prostate cancer, but also may be a meaningful indicator to judge the prognosis of prostate cancer